ORXRF.PK on USA Pink Sheets

0.17USD
9 Feb 2010
Price Change (% chg)

$0.03 (+20.00%)
Prev Close
$0.17
Open
--
Day's High
$0.17
Day's Low
$0.16
Volume
150,000
Avg. Vol
11,285
52-wk High
$0.21
52-wk Low
$0.07

ORXRF.PK

Chart for ORXRF.PK

About

No overview information found for ORXRF.PK.
No analyst recommendations are available for ORXRF.PK.

Overall

No Ratios Available.

Financials

view overview for:

Orexigen reaches settlement agreement with Eisai

Sept 19 (Reuters) - Orexigen Therapeutics Inc said it reached a settlement agreement with Japanese drugmaker Eisai Co Ltd over a previously resolved lawsuit related to the use of zonisamide for treating obesity.

19 Sep 2007

TABLE-Orexigen Q2 results

OREXIGEN THERAPEUTICS INC. (In $) Latest Yr ago qtr Loss/shr (diluted) 0.63 2.48 Net loss (million) 11.6 5.4 Total revenue (thousands) 22 21 Reuters Estimates: Loss/shr $0.54 (three analysts), revenue $0.02 million (two analysts).

09 Aug 2007

Orexigen says obesity drug met main goal of trial

BOSTON, July 24 (Reuters) - Orexigen Therapeutics Inc. said on Tuesday that its experimental obesity drug met the main goal of a mid-stage clinical trial.

24 Jul 2007

  Earnings  vs    Estimates

No consensus analysis data available.
view overview for: